HIF-1α suppresses myeloma progression by targeting Mcl-1

被引:1
|
作者
Wu, Feng [1 ]
Tong, Dong-Dong [2 ]
Ni, Lei [2 ]
Wang, Lu-Min [2 ]
Wang, Meng-Chang [3 ]
机构
[1] Xi An Jiao Tong Univ, Ctr Teaching & Expt Med Post Grad, Sch Med, Xian, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Cell Biol & Genet, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hematol, Xian, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
HIF-1; alpha; Mcl-1; MMs; proliferation; apoptosis; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER; CELLS; PROLIFERATION; APOPTOSIS; PATHWAY; VEGF;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HIF-1 alpha is involved in the carcinogenesis and progression of multiple types of cancer. However, the precise role of HIF-1 alpha is unclear in multiple myeloma. Through the qRT-PCR and CCK-8 assays, we demonstrated that silenc-ing the expression of HIF-1 alpha and Mcl-1, MM proliferation can be decreased and apoptosis can be induced. Next, using the GEO database, we found that Mcl-1 was increased in MMs. Mcl-1 overexpression counterbalanced the tumor suppressing effect of siHIF-1 alpha on MM apoptosis. Additionally, HIF-1 alpha acting as a transcription factor, could directly target the promoter region of Mcl-1 to promote Mcl-1 expression. Based on the experimental result, our find-ings strongly suggest that HIF-1 alpha regulated the progression of MMs by directly targeting the Mcl-1.
引用
收藏
页码:1483 / +
页数:10
相关论文
共 50 条
  • [31] Mcl-1: the 1 in CLL
    Gandhi, Varsha
    Balakrishnan, Kumudha
    Chen, Lisa S.
    BLOOD, 2008, 112 (09) : 3538 - 3540
  • [32] Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
    Kuroda, Junya
    Kamitsuji, Yuri
    Kimura, Shinya
    Ashihara, Eishi
    Kawata, Eri
    Nakagawa, Yoko
    Takeuichi, Miki
    Murotani, Yoshihide
    Yokota, Asumi
    Tanaka, Ruriko
    Andreeff, Michael
    Taniwaki, Masafumi
    Maekawa, Taira
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 87 (05) : 507 - 515
  • [33] MCL-1 inhibits BAX in the absence of MCL-1/BAX interaction
    Germain, Marc
    Milburn, Jocelyn
    Duronio, Vincent
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (10) : 6384 - 6392
  • [34] Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
    Junya Kuroda
    Yuri Kamitsuji
    Shinya Kimura
    Eishi Ashihara
    Eri Kawata
    Yoko Nakagawa
    Miki Takeuichi
    Yoshihide Murotani
    Asumi Yokota
    Ruriko Tanaka
    Michael Andreeff
    Masafumi Taniwaki
    Taira Maekawa
    International Journal of Hematology, 2008, 87 : 507 - 515
  • [35] Evaluation of Mcl-1 Inhibitors in Preclinical Models of Multiple Myeloma
    Belmonte, Matthew A.
    Adam, Ammar
    Borrelli, Deanna
    Bhavsar, Deepa
    Bebernitz, Christina
    Hird, Alexander
    Secrist, Paul
    BLOOD, 2014, 124 (21)
  • [36] Targeting the PAS-A domain of HIF-1α for development of small molecule inhibitors of HIF-1
    Park, Eun Jung
    Kong, Dehe
    Fisher, Robert
    Cardellina, John
    Shoemaker, Robert H.
    Melillo, Giovanni
    CELL CYCLE, 2006, 5 (16) : 1847 - 1853
  • [37] Targeting TRMT5 suppresses hepatocellular carcinoma progression via inhibiting the HIF-1α pathways靶向TRMT5抑制HIF-1α信号通路调控肝癌进程
    Qiong Zhao
    Luwen Zhang
    Qiufen He
    Hui Chang
    Zhiqiang Wang
    Hongcui Cao
    Ying Zhou
    Ruolang Pan
    Ye Chen
    Journal of Zhejiang University-SCIENCE B, 2023, 24 : 50 - 63
  • [38] Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex
    Patricia Gomez-Bougie
    Lisa Oliver
    Steven Le Gouill
    Régis Bataille
    Martine Amiot
    Oncogene, 2005, 24 : 8076 - 8079
  • [39] HIF-1 and tumor progression: pathophysiology and therapeutics
    Semenza, GL
    TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) : S62 - S67
  • [40] HIF-1α:: An epithelial careinogenesis progression factor
    Arbeit, JM
    Wright, JD
    Elson, DA
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S24 - S25